Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Redmile Group, Llc Insider Profile
11 Followers
Redmile Group, Llc, Ten Percent Owner at Array Biopharma, holds 1.86M shares in RayzeBio, Inc. (Ticker: RYZB), holds 15.65M shares in Augmedix (Ticker: AUGX), holds 5.95M shares in IGM Biosciences (Ticker: IGMS).
Redmile Group, Llc Array Biopharma (~ARRY)Ten Percent Owner
Array Biopharma (~ARRY)
Ten Percent Owner
Ranked #41,277 out of 104,081 Corporate Insiders
Profitable Transactions
12 out of 35 Profitable Transactions
Average Return
+0.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Redmile Group, Llc holds in companies
Most Profitable Insider Trade
The most profitable trade made by Redmile Group, Llc
Redmile Group, Llc's Trading History
Array Biopharma
Sep 30, 2016
―
Informative Sell
15.85M
$916.36M
Amicus
Jun 13, 2016
Ten Percent Owner
Informative Buy
―
$158.55M
Alder Biopharmaceuticals
Oct 24, 2019
―
Uninformative Sell
―
$0.00
Xeris Pharmaceuticals
Feb 21, 2019
Ten Percent Owner
Informative Buy
5.88M
$5.70M
Allakos
Jul 24, 2018
Ten Percent Owner
Uninformative Buy
―
$2.17M
Replimune Group
Jul 25, 2018
Ten Percent Owner
Uninformative Buy
―
$12.96M
Fate Therapeutics
Apr 21, 2023
Director, Ten Percent Owner
Informative Buy
1.71M
$29.56M
Gritstone Oncology
Oct 03, 2018
Ten Percent Owner
Uninformative Buy
―
$1.81M
Vapotherm
Nov 16, 2018
Ten Percent Owner
Uninformative Buy
―
$2.88M
TCR2 Therapeutics
Feb 21, 2019
―
Uninformative Buy
―
$1.19M
Hookipa Pharma
Apr 24, 2019
Ten Percent Owner
Uninformative Buy
―
$611.59K
IGM Biosciences
Jul 03, 2023
Director
Informative Buy
757.58K
$41.46M
Cabaletta Bio
Oct 29, 2019
Ten Percent Owner
Uninformative Buy
―
$11.16M
Aprea Therapeutics
Feb 16, 2021
Ten Percent Owner
Informative Sell
2.79M
$7.69M
Atreca
Jun 24, 2019
Ten Percent Owner
Uninformative Buy
―
$236.05K
Akero Therapeutics
Jun 24, 2019
Ten Percent Owner
Uninformative Buy
―
$36.15M
Stoke Therapeutics
Jun 24, 2019
Ten Percent Owner
Uninformative Buy
―
$2.98M
Beam Therapeutics
Feb 11, 2020
Ten Percent Owner
Uninformative Buy
―
$29.30M
Neoleukin Therapeutics
Apr 06, 2020
Ten Percent Owner
Informative Buy
2.01M
$2.99M
Pliant Therapeutics
Jun 09, 2020
Ten Percent Owner
Uninformative Buy
―
$31.20M
Repare Therapeutics
Jun 25, 2020
Ten Percent Owner
Uninformative Buy
―
$20.64M
Nurix Therapeutics
Jul 30, 2020
Ten Percent Owner
Uninformative Buy
―
$10.86M
Annexon Biosciences
Jul 30, 2020
Ten Percent Owner
Uninformative Buy
―
$4.18M
AlloVir
Aug 05, 2020
Ten Percent Owner
Uninformative Buy
―
$1.88M
Kymera Therapeutics
Aug 25, 2020
Ten Percent Owner
Uninformative Buy
―
$28.39M
Shattuck Labs
Oct 15, 2020
Director, Ten Percent Owner
Uninformative Buy
―
$9.33M
Verve Therapeutics
Jun 23, 2021
Ten Percent Owner
Uninformative Buy
―
$24.81M
AbSci
Jul 28, 2021
Director
Uninformative Buy
―
$12.21M
Invivyd
Aug 12, 2021
Ten Percent Owner
Uninformative Buy
―
$5.93M
Science 37
May 15, 2023
Director, Ten Percent Owner
Uninformative Buy
123.71K
$6.96M
Augmedix
Sep 05, 2023
Director, Ten Percent Owner
Uninformative Buy
10.00K
$82.18M
Entrada Therapeutics Inc
Nov 04, 2021
Ten Percent Owner
Uninformative Buy
―
$27.75M
MedAvail Holdings
Jul 06, 2022
Director, Ten Percent Owner
Uninformative Buy
18.07M
$339.13M
Zymeworks
Oct 17, 2022
Ten Percent Owner
Uninformative Buy
153.32K
$40.34M
RayzeBio, Inc.
Sep 21, 2023
Ten Percent Owner
Uninformative Buy
―
$39.01M
List of latest transactions for each holding click on a transaction to see Redmile Group, Llc's performance on stock
You May Also Like
Redmile Group, Llc insider profile FAQ
What is the percentage of profitable transactions made by Redmile Group, Llc?
The percentage of profitable transactions made by Redmile Group, Llc is 34%.
What is the average return per transaction made by Redmile Group, Llc?
The average return per transaction made by Redmile Group, Llc is 0.60%.
What stocks does Redmile Group, Llc hold?
Redmile Group, Llc holds: ~ARRY, FOLD, ALDR, XERS, ALLK, REPL, FATE, GRTS, VAPO, TCRR, HOOK, IGMS, CABA, APRE, BCEL, AKRO, STOK, BEAM, NLTX, PLRX, RPTX, NRIX, ANNX, ALVR, KYMR, STTK, VERV, ABSI, IVVD, SNCE, AUGX, TRDA, MDVL, ZYME, RYZB stocks.
What was Redmile Group, Llc’s latest transaction?
Redmile Group, Llc latest transaction was an Uninformative Buy of ―.
What was Redmile Group, Llc's most profitable transaction?
Redmile Group, Llc’s most profitable transaction was an Informative Buy of FATE stock on June 17, 2020. The return on the trade was 165.20%.
What is Redmile Group, Llc's role in Array Biopharma?
Redmile Group, Llc's role in Array Biopharma is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.